Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025Endocrine Metabolic & Immune Disorders - Drug Targets

Improving Immune Checkpoint Therapy in the Tumor Microenvironment by Targeting T Cell Metabolism

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJun WeiBABaozhen AnRDRenchao Dong

Discussion

Loading...

Member takes

Overview

Observational analysis shows metabolic competition hinders T cell activation in the tumor microenvironment, suggesting new therapeutic avenues.

Key Points

  • Increased T cell metabolism is essential for immune function, but competition with tumor cells reduces effectiveness.
  • Limited availability of crucial nutrients like glucose and amino acids impairs T cell proliferation within the tumor microenvironment.
  • Cytokines and immune checkpoints play a significant role in T cell behavior, impacting overall immune response.
  • Modulating tumor and T cell metabolism offers new strategies for enhancing cancer treatment and patient outcomes.

Cite This Study

Wei et al. (2025) studied this question.

synapsesocial.com/papers/68e02f40f0e39f13e7fa29d6https://doi.org/10.2174/0118715303400871250821103310
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Metabolic Constraints and Interactions Drive T-cell Function and Exhaustion in Cancer Progression2026
  2. 2Metabolic Reprogramming of the Tumor Microenvironment to Enhance Response to Immunotherapy2024 · 30 citations
  3. 3Metabolic Bottlenecks and Opportunities: Reshaping the Tumor Microenvironment for Cancer Immunotherapy2026
  4. 4Metabolic–immune nexus in tumor microenvironment: From mechanistic insights to therapeutic opportunities2025 · 13 citations
  5. 5Metabolic rewiring of the tumor microenvironment: therapeutic intervention of multi-pathway adaptations to impede cancer metastasis2026 · 1 citations